Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Management

David Wood, M.B.A., C.M.A.
Head of Finance and Corporate Development


Mr. Wood has held management positions in both large corporations and early stage companies in Canada and the UK. Most recently he was Managing Director of Cubist Pharmaceuticals (UK) Ltd. Prior to that he was Senior Director, International Operations of Cubist Pharmaceuticals Inc., and Finance Director at TerraGen Discovery, Inc. Mr. Wood received an MBA from the Ivey Business School of the University of Western Ontario, a BSc in Biology, and a CMA accounting designation.

< return

 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.